Intrahepatic Splenosis in a Chronic Hepatitis C Patient with no History of Splenic Trauma Mimicking Hepatocellular Carcinoma

被引:17
作者
Sato, Naoya [1 ,2 ]
Abe, Tsuyoshi [1 ]
Suzuki, Nobuyasu [1 ]
Waragai, Mitsuru [1 ]
Teranishi, Yasushi [1 ]
Takano, Yoshinao [1 ]
Sato, Atai [1 ]
Azami, Ayaka [1 ]
Gotoh, Mitsukazu [2 ]
机构
[1] Southern Tohoku Res Inst Neurosci, Dept Surg, Koriyama, Fukushima, Japan
[2] Fukushima Med Univ, Dept Regenerat Surg, Fukushima, Japan
来源
AMERICAN JOURNAL OF CASE REPORTS | 2014年 / 15卷
关键词
Hepatitis; Chronic; Liver Neoplasms; Splenosis;
D O I
10.12659/AJCR.890999
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Rare disease Background: Intrahepatic splenosis (IHS) is the autotransplantation of splenic tissue that mostly develops after abdominal injury and is often misdiagnosed as hepatocellular carcinoma (HCC) because of similarities in radiological features. We had an opportunity to treat an extremely rare case of intrahepatic splenosis, which were found in a patient without any history of splenic injury. To the best of our knowledge, this is the first such case report in the world. Case Report: A 58-year-old man with chronic hepatitis C was referred to our hospital for further examination of liver function abnormality. Abdominal ultrasonography incidentally revealed a low echoic tumor in the posterior segment of the liver, with high echoic capsule, which is possibly different from tumor capsule of HCC, known as halo. Abdominal contrast-enhanced computed tomography and gadoxetic acid-enhanced magnetic resonance imaging showed that the tumor had an inhomogeneous enhancement in the arterial phase and diminished enhancement in the equilibrium phase, diagnosed as HCC. The patient underwent right lateral segmentectomy of the liver, and histopathological study confirmed a diagnosis of intrahepatic splenosis. Conclusions: This case presents a new understanding of IHS in a patient without any splenic injury. We also focused on the differences in echo patterns of the tumor capsule between HCC and IHS, which can be used to efficiently diagnose IHS.
引用
收藏
页码:416 / 420
页数:5
相关论文
共 50 条
  • [21] A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma
    Darvishi, Mohammad
    Nouri, Majid
    Rahimi, Rasoul
    Heidari-Soureshjani, Saeid
    Rafsanjani, Seyed Mahmoud Reza Hashemi
    CURRENT MOLECULAR MEDICINE, 2024,
  • [22] Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients
    Namkyu Kang
    Jung Wha Chung
    Eun Sun Jang
    Sook-Hyang Jeong
    Jin-Wook Kim
    Digestive Diseases and Sciences, 2021, 66 : 4536 - 4544
  • [23] Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients
    Kang, Namkyu
    Chung, Jung Wha
    Jang, Eun Sun
    Jeong, Sook-Hyang
    Kim, Jin-Wook
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4536 - 4544
  • [24] Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future
    Yoshizawa, H
    ONCOLOGY, 2002, 62 : 8 - 17
  • [25] Hepadnavirus DNA Is Detected in Canine Blood Samples in Hong Kong but Not in Liver Biopsies of Chronic Hepatitis or Hepatocellular Carcinoma
    Choi, Yan Ru
    Chen, Min-Chun
    Carrai, Maura
    Rizzo, Francesca
    Chai, Yingfei
    Tse, May
    Jackson, Ken
    Martella, Vito
    Steiner, Joerg
    Pesavento, Patricia A.
    Beatty, Julia A.
    Barrs, Vanessa R.
    VIRUSES-BASEL, 2022, 14 (07):
  • [26] Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study
    Wang, Zhi
    Gou, Wenbin
    Liu, Ming
    Sang, Wei
    Chu, Hui
    Zhang, Wei
    MEDICAL SCIENCE MONITOR, 2015, 21 : 3209 - 3215
  • [27] Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C
    Duffell, Erika
    Cortez-Pinto, Helena
    Simonova, Marieta
    Dalgard, Olav
    Dahl, Elin Hoffmann
    de Martel, Catherine
    Mozalevskis, Antons
    Buti, Maria
    Pavlova, Slava
    Hadzhilova, Tnaiq
    Simoes, Carolina
    Katzarov, Krum
    Mardh, Otilia
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (08) : 1177 - 1189
  • [28] The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
    Chinchilla-Lopez, Paulina
    Qi, Xingshun
    Yoshida, Eric M.
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 328 - 330
  • [29] Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
    Ahn, Young-Hwan
    Lee, Heirim
    Kim, Do Young
    Lee, Hye Won
    Yu, Su Jong
    Cho, Young Youn
    Jang, Jeong Won
    Jang, Byoung Kuk
    Kim, Chang Wook
    Kim, Hee Yeon
    Park, Hana
    Cho, Hyo Jung
    Park, Bumhee
    Kim, Soon Sun
    Cheong, Jae Youn
    GUT AND LIVER, 2021, 15 (03) : 410 - 419
  • [30] Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
    Chun, Ho Soo
    Lee, Minjong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 448 - 450